The potential reclassification of cannabinoids, particularly at the federal level, is generating considerable anticipation within the market. A shift away from Schedule I status, often regarded as outdated and https://mathevasl882060.wikifrontier.com/8671422/cannabinoid_rescheduling_a_growth_catalyst